April 22–25, 2026 — Limited Seats
FxMedCE Presents
Cardiometabolic
Summit
Stop managing numbers in silos. Master the whole metabolic pattern.
The systems-based framework that changes how you see — and treat —
cardiometabolic disease.
12
Total Hours
9
CE/CME Credits
3
Live Sessions
6
On-Demand Modules
Replay access included · Downloadable framework tools
The Reality Check
What If Your “Normal” Labs
Are Lying to You?
Every day, patients with “normal” results are progressing toward heart disease, diabetes, and fatty liver. Here’s what you’re missing.
Normal LDL
→ but elevated ApoB
“Normal” A1C
→ but clear hyperinsulinemia
Mildly elevated ALT
→ but metabolic liver disease progressing
Controlled blood pressure
→ but ongoing vascular dysfunction
The Missing Piece
A unified clinical framework connecting metabolic, inflammatory, vascular, hepatic, hormonal, and mitochondrial drivers — before traditional thresholds are ever crossed.
Traditional Approach
- Manage isolated numbers in silos
- React after diagnostic thresholds are crossed
- Either/or thinking: meds vs. lifestyle
- Miss upstream metabolic drivers
After This Summit
- See the whole cardiometabolic pattern
- Identify dysfunction before diagnosis
- Integrate pharmacology + lifestyle strategically
- Build longitudinal care plans that work
Five Clinical Superpowers You’ll Walk Away With
Skills you can apply with your very next patient.
Identify dysfunction before diagnostic thresholds
Interpret discordant laboratory patterns
Integrate pharmacology and lifestyle strategically
Escalate workup in fatty liver and metabolic disease
Build longitudinal care plans that reflect reality
This Is Why It Matters
⊙ A Real Clinical Scenario
“A 47-year-old woman. BMI 31. ‘Normal’ A1C at 5.6, ‘normal’ LDL at 118. Her PCP told her everything looked fine. But her fasting insulin was 22, ApoB was 142, ALT was 48, and her waist circumference was 38 inches. She was already deep into metabolic dysfunction — and nobody saw it.”
This summit teaches you to see what traditional markers miss. To connect the dots across metabolic, inflammatory, vascular, and hepatic systems — and intervene before disease fully declares itself.
Because your patients can’t afford to wait for “abnormal.”
47%
of first cardiac events occur in people classified as “low risk”
88M+
Americans with metabolic syndrome — most undiagnosed
Built for Clinicians Who Care About Upstream Thinking
Pharmacists
Physicians
Nurse Practitioners
Physician Associates
Nurses
New to Systems-Based Practice?
Gain a cohesive cardiometabolic model that moves beyond siloed care. Build a foundation of integrated clinical thinking you can use from day one.
Experienced Practitioner?
Sharpen clinical reasoning, reinforce evidence-based integration, and enhance risk stratification across complex metabolic phenotypes.
This Is Not Wellness Education
This is applied cardiometabolic clinical strategy.
Framework-driven, not protocol-driven
Clinically anchored & risk-aware
Evidence-informed + pharmacology-inclusive
Built for real practice constraints
Designed for immediate implementation
Complete Curriculum
Summit Structure & Curriculum
5 hours of on-demand pre-work followed by 3 live sessions — a total of 12 hours of systems-based cardiometabolic training.
12 Hours
Total Training
9 CE/CME
Accredited Hours
3 Live
Interactive Sessions
Tools
Downloadable Frameworks
On-Demand Pre-Work
5 hours CE — Build the foundation before we go live
1Big Picture: The Cardiometabolic Web
Differentiate a systems-based cardiometabolic framework from traditional siloed approaches
Describe how pattern recognition across metabolic, inflammatory, vascular, and adipose pathways enhances early risk identification
Identify lifestyle- and nutrition-based intervention targets that influence cardiometabolic risk trajectories
Identify common cardiometabolic risk patterns even when standard lab values appear within reference ranges
2Diabetes + Insulin Resistance Core
Describe the continuum from insulin resistance and prediabetes to overt type 2 diabetes
Recognize hyperinsulinemia as a primary driver of cardiometabolic risk
Identify common clinical patterns of dysglycemia including postprandial glucose abnormalities
Apply pattern-based interpretation of glucose and insulin markers
3Liver: NAFLD/MASLD/MASH as a Risk Engine
Recognize fatty liver disease as a central driver of cardiometabolic risk
Interpret liver enzymes within the broader context of metabolic, lipid, and glucose abnormalities
4Heart Disease Applications
Apply a cardiometabolic framework to CAD and ASCVD assessment
Explain metabolic contributions to heart failure with preserved ejection fraction (HFpEF)
Recognize cardiovascular symptoms and red flags warranting urgent evaluation
Describe key components of cardiometabolic optimization for patients with established CVD
5Related Metabolic Dysfunction: Obesity, PCOS, Osteoporosis, Cancer & More
Recognize PCOS as a phenotype of insulin resistance and metabolic dysfunction
Explain cancer as a metabolically influenced disease using a systems-based framework
Discuss how metabolic dysfunction contributes to osteopenia and osteoporosis
Apply pattern recognition across conditions to inform upstream risk assessment
6Pharmacology for Cardiometabolic Care
Compare mechanisms for key pharmacotherapies: metformin, GLP-1 RAs, dual incretin therapies, SGLT2 inhibitors
Apply decision rules to lipid-lowering therapies — statins, ezetimibe, niacin, PCSK9 inhibitors, bempedoic acid
Identify first-line antihypertensive medication classes and metabolically favorable options
Implement strategies to mitigate medication-related side effects
Integrate pharmacologic therapy with lifestyle and nutritional interventions
Live Sessions
4 hours CE + 3 hours non-CE case synthesis
Live Session 1
April 22, 7 PM EST
(2 hours)
Dyslipidemia + ASCVD Risk Beyond LDL (45 min)
Hypertension + Vascular Health (45 min)
Gut–Heart–Metabolism Connection (30 min)
Live Session 2
April 23, 7 PM EST
(2 hours)
Functional Drivers: Mitochondria, Hormones, Environment (30 min)
Nutrition + Lifestyle Rx That Moves Outcomes (45 min)
Top Evidence-Based Nutraceuticals for CM Health (45 min)
Live Case-Based Synthesis
April 25, 10 AM EST
(3 hours)
Non-CE
IR + HTN + Dyslipidemia Case
NAFLD/MASH + Elevated ApoB Case
PCOS Phenotype Case
ASCVD Secondary Prevention Case
Case-Based Approach: For each case, walk through assessment → labs → priorities → Rx (lifestyle + meds) → follow-up plan. This is where theory becomes clinical clarity.
EXPERT FACULTY
Your Summit Speakers
Three leading clinician-educators bringing complementary expertise to the cardiometabolic framework.
Dr. Tom Guilliams
PhD
Molecular Immunologist & Author
Dr. Melody Hartzler
PharmD, BCACP, BC-ADM, ABAAHP
Clinical Pharmacist & Metabolic Specialist
Dr. Lara Zakaria
PharmD, MS, CNS, CDN, IFMCP
Clinical Pharmacist & Nutritionist
Early Registration Bonus
Register by March 31st — Get Free Fatty Liver CE
Receive complimentary access to Dr. Elyaman’s Fatty Liver CE program on April 17th. A high-value standalone CE — included at no additional cost.
The progression from NAFLD to MASLD/MASH
Risk stratification beyond standard liver enzymes
Practical intervention strategies
When to escalate evaluation or specialty referral
Because cardiometabolic mastery
begins in the liver.
Offer Ends
March 31, 2026
AKH Inc is an accredited provider through Joint Accreditation. AKH and Revelar Health LLC are jointly providing credit for this activity. It will be awarded AMA PRA Category 1 Credit(s)™, ACPE, AAPA, AANP, and ANCC credit.
Cardiometabolic Disease Is Rising.
Our Framework Must Evolve.
Your patients deserve upstream thinking.
You deserve a model that makes sense of complexity.
Join us April 22–25.
Learn the framework. Lead differently.
12 total hours | 9 CE/CME hours | 3 live sessions | 5 hours on-demand | Downloadable tools & frameworks